Palmoplantar Pustulosis (PPP) Study - Enrolling

Portland, Oregon
Clinical Trial
Psoriasis

Palmoplantar Pustulosis (or PPP) is a rare, chronic inflammatory skin condition affecting the palms and/or soles of the feet. It is characterized by small, painful, recurrent white-to-brown spots on the hands and feet on a background of red, flaky skin. It may occur in patients who also have plaque psoriasis on other parts of the body.

Oregon Medical Research Center is conducting a clinical research study to evaluate the efficacy of an investigational topical cream for adults with mild to severe PPP. If you have experienced PPP symptoms for at least 6 months, you may qualify. The study lasts up to 22 weeks and participation is voluntary with no costs or health insurance is required. Compensation for time and travel reimbursement may be provided.

Palmoplantar Pustulosis can make everyday activities difficult, and there is currently no FDA-approved treatment for PPP. Your participation may help improve your symptoms and advance the understanding and future treatment options for PPP.

Learn More
OMRC PPP Study QR code

MyStudies Partner:

Oregon Medical Research Center logo

Get Notified About Upcoming Trials

Sign up to receive information about clinical trials, studies, and surveys in your area – right to your inbox.

Sign up

Featured MyStudies represents promotional content from our partners. Information contained in these listings is for general informational purposes only and does not constitute an endorsement, recommendation, or certification of any kind by NPF. Persons participating in trials, studies, or surveys assume responsibility for their participation and are advised to discuss the information shown with their health care provider.

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity Navigator

Copyright © 1996-2026 National Psoriasis Foundation/USA


The National Psoriasis Foundation is a qualified 501(c)(3) EIN 93-0571472.


Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.